ABSTRACT
Falls on stairs occur frequently and pose a significant health and financial risk. Laboratory research has found that fall frequency can be reduced through contrast enhancement of the stairs by applying vinyl striping to the first and last steps’ faces, and all the steps’ top edges. Here we sought to determine if such step contrast enhancement can reduce the probability of fall-related events such as loss of balance, slips, trips, and falls in public university staircases. Cameras were used to capture stair users’ ascent and descent on contrast enhanced (‘striped’) and control stairways. Observed age group, observed gender, traverse direction (ascent, descent), fall-related events, and walking speed (m/s) were recorded. Fall-related events were reduced for the striped stairway compared to the control stairway (odds ratio = 2.87, average marginal effect = 0.002, p = .023) when controlling for observed gender, age category, and traverse direction. These results suggest contrast enhancement of first and last steps’ face and all steps’ edges may reduce fall- related events in public settings. Adding contrast enhancement to public stairways is a simple and cost-effective way to reduce the loss of balance, slips, and trips that could lead to catastrophic falls on stairs as well as the health and financial burden associated with such falls.
PRECIS Contrast enhancement of stairway features may be a simple and cost-effective way to reduce falls on stairs. We show that monochrome striping on the first and last steps’ faces and black stripes on steps’ top edges reduce the probability of fall-related events in public stairways.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Utah State University Undergraduate Research & Creative Opportunity (URCO) Award (2020 Christopher Long, Samantha Corbridge), American Heart Association (Postdoctoral Fellowship 20POST34990005 Sara A. Harper).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board at Utah State University gave ethical approval of this work (Protocol #10773).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The research support was provided by Utah State University Undergraduate Research & Creative Opportunity (URCO) Award (2020 – Christopher Long, Samantha Corbridge), American Heart Association (Postdoctoral Fellowship 20POST34990005 Sara A. Harper).
Data Availability
The data is not currently available.
